Healthy obese subjects without NAFLD had lower Adgrf1 mRNA expression than healthy lean subjects, but obese NAFLD subjects had similar Adgrf1 mRNA expression level as healthy lean subjects (Figure 9A). This evidence concerns the gene ADGRF1 and metabolic dysfunction-associated steatotic liver disease.